ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

No reported Operating Expenses figures are available to summarize.

Operating Expenses history

Currency unavailable · from the income statement

No Operating Expenses data reported for this period type.

Operating Expenses vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Operating Expenses for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$264.22M USD+15.6%+14.4%368.0%
STOKStoke Therapeutics, Inc.LTM Mar 2026$214.24M USD+41.4%+20.6%667.8%
MGTXMeiraGTx Holdings plcLTM Mar 2026$178.28M USD+5.9%+11.3%223.5%
PRMEPrime Medicine, Inc.LTM Mar 2026$162.94M USD-22.5%+20.8%4039.1%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$130.57M USD-39.9%-10.4%287.9%
RNAAtrium Therapeutics, Inc.FY2025$95.43M USD——512.6%
SLNSilence Therapeutics plcLTM Mar 2026$87.2M USD—+16.9%9463.1%
PRQRProQR Therapeutics N.V.LTM Mar 2026€58.51M EUR+12.1%-7.3%435.3%
BNTCBenitec Biopharma Inc.LTM Mar 2026$53.82M USD+43.6%+32.6%—
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+12.1%+15.6%473.9%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.